Centene Corporation (CNC)

Check out top investors' recommendation for CNC
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
106.38
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Centene Corporation provides multi-line healthcare programs and services in the United States. It operates in two segments, Medicaid Managed Care and Specialty Services. The Medicaid Managed Care segment provides Medicaid and Medicaid-related health plan coverage to individuals through government subsidized programs, including Medicaid, the State children’s health insurance program, long-term care, foster care, and Medicare special needs plans, as well as aged, blind, or disabled programs. Its health plans provide primary and specialty physician care, inpatient and outpatient hospital care, transportation assistance, emergency and urgent care, vision care, prenatal care, dental care, laboratory and x-ray services, immunizations, prescriptions and over-the-counter drugs, home health and durable medical equipment, behavioral health and substance abuse services, therapies, social work services, care coordination, and 24-hour nurse advice line. The Specialty Services segment manages behavioral healthcare for members; provides health insurance to individual customers and their families; implements life and health management programs; offers long-term care services to the elderly and people with disabilities; and administers routine and medical surgical eye care benefits through its network of eye care providers. It also offers telehealth services; and claims processing, pharmacy network management, benefit design consultation, drug utilization review, formulary and rebate management, specialty and mail order pharmacy services, and patient and physician intervention services, as well as provides care management solutions that automate the clinical, administrative, and technical components of care management programs. The company offers its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Sector:
Industry:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Steven Halper Lazard Capital Markets Buy   Oct 24, '17     107.00  Oct 24, '18  N/A 
Michael Wiederhorn Oppenheimer & Co. Buy   Oct 24, '17     105.00  Oct 24, '18  N/A 
Christine Arnold Cowen And Company Buy   Oct 23, '17     115.00  Oct 23, '18  N/A 
Sarah James Wedbush Securities Inc. Buy   Oct 13, '17     112.00  Oct 13, '18  N/A 
David Windley Jefferies & Co. Buy   Oct 13, '17     112.00  Oct 13, '18  N/A 
Michael Wiederhorn Oppenheimer & Co. Buy   Sep 12, '17     95.00  Sep 12, '18  N/A 
Steven Halper Lazard Capital Markets Buy   Sep 12, '17     107.00  Sep 12, '18  N/A 
David Windley Jefferies & Co. Buy   Sep 05, '17     98.00  Sep 05, '18  N/A 
Ralph Giacobbe Credit Suisse Sell   Jul 26, '17     89.00  Jul 26, '18  N/A 
Michael Wiederhorn Oppenheimer & Co. Buy   Jul 25, '17     89.00  Jul 25, '18  N/A 
Steven Halper Lazard Capital Markets Buy   Jul 25, '17     90.00  Jul 25, '18  N/A 
Sarah James Wedbush Securities Inc. Buy   Jul 25, '17     105.00  Jul 25, '18  N/A 
Steven Halper Lazard Capital Markets Buy   Jun 19, '17     90.00  Jun 19, '18  N/A 
Thomas Carroll Stifel Nicolaus & Company, Inc. Buy   Apr 26, '17     85.00  Apr 26, '18  N/A 
Joseph France Cantor Fitzgerald Buy   Apr 25, '17       Apr 25, '18  N/A 
Joseph France Cantor Fitzgerald Buy   Feb 06, '17     85.00  Feb 06, '18  N/A 
Michael Wiederhorn Oppenheimer & Co. Buy   Jan 17, '17     89.00  Jan 17, '18  N/A 
Justin Lake JPMorgan Buy   Dec 21, '16       Dec 21, '17  N/A 
David Windley Jefferies & Co. Buy   Dec 16, '16     68.00  Dec 16, '17  N/A 
Joseph France Cantor Fitzgerald Buy   Sep 29, '16       Sep 29, '17  N/A 
< previous12345